Interventional Cardiology Devices – Market Insights – Europe (Supplemental)

The European IC device market has been able to recover from the COVID-19 pandemic and is seen as reverting to pre-pandemic sales. Steady uptake of several technologies has supported the IC device space and will continue to do so over the forecast period. In addition, premium priced advanced technologies are poised to enter the market, which could potentially change the existing treatment algorithms, disrupting the established category leaders.

This Medtech 360 Report provides high-level market metrics for IC devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.

Table of contents

Interventional Cardiology Devices - Market Insights - Europe (Supplemental)

Anusha Naik

Anusha Naik is a member of the Cardiovascular Medtech Insights team at Clarivate, specializing in the heart valve device market. Anusha holds a Bachelor’s degree in Pharmaceutical Sciences from Goa College of Pharmacy, Goa and a Master’s degree in Pharmaceutical Quality Assurance from the Manipal Academy of Higher Education, Manipal.

Sangeetha Iyer, Pharm.D

Sangeetha Iyer is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markets across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represented India at the European Society of Cardiology conference in Greece (2016) and Sweden (2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG

Contact sales Login to access report

Back to all Medtech Insights reports